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Research
Nested Case-Control Study of Autoimmune Disease in an Asbestos-Exposed
Population
CurtisW. Noonan,1Jean C. Pfau,1TheodoreC. Larson,2and MichaelR. Spence3
1Centerfor EnvironmentalHealth Sciences, University of Montana, Missoula, Montana, USA;2Agency for Toxic Substances and Disease
Registry, Centers for Disease Controland Prevention, Atlanta, Georgia, USA; 3MontanaDepartmentof Health and Human Services,
Helena, Montana, USA

betweenasbestosexposureandriskof autoimmune
OBJECTIVE:To explorethe potentialassociation

disease,we conducteda case-controlstudyamonga cohortof 7,307 currentand formerresidents
of Libby,Montana,a communitywith historicaloccupationaland environmentalexposureto
asbestos-contaminated
vermiculite.
METHODS:
Caseswere definedas those who reportedhavingone of threesystemicautoimmune
diseases (SAIDs):systemiclupus erythematosus,scleroderma,or rheumatoidarthritis(RA).
Controlswererandomlyselectedat a 3:1 ratiofromamongthe remaining6,813 screeningparticipantsusingfrequency-matched
ageandsexgroupings.
The odds ratios (ORs) and 95% confidenceintervals(CIs) for SAIDs among those
RESULTS:
> 65 yearsof age who had workedfor the vermiculitemining companywere 2.14 (95% CI,
0.90-5.10) for all SAIDsand 3.23 (95% CI, 1.31-7.96) for RA. In this age group,exposureto
asbestoswhile in the militarywas also an independentriskfactor,resultingin a triplingin risk.
Othermeasuresof occupationalexposureto vermiculiteindicated54%and 65% increasedriskfor
SAIDsand RA, respectively.Those who had reportedfrequentcontactwith vermiculitethrough
variousexposurepathwaysalsodemonstrated
elevatedriskforSAIDsandRA.We foundincreasing
risk estimatesfor SAIDs with increasingnumbersof reportedvermiculiteexposurepathways
(p < 0.001).

CONCLUSION:
Thesepreliminaryfindingssupportthe hypothesisthat asbestosexposureis associatedwith autoimmunedisease.Refinedmeasurements
of asbestosexposureandSAIDstatusamong
this cohortwill helpto furtherclarifythe relationship
betweenthesevariables.
KEYWORDS:
vermiculite.
asbestos,autoimmune,Libby,lupus,rheumatoidarthritis,scleroderma,
Environ Health Perspect 114:1243-1247 (2006). doi:10.1289/ehp.9203 available via
[Online30 May2006]
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An associationbetweenoccupationalexposures
of inhaledparticulatesand autoimmunitywas
postulated as early as 1914, when Bramwell
(1914) reportedincreasedfrequencyof diffuse
scleroderma(SSc) in stone masons.Although
geneticfactorsundoubtedlyexistthat affectthe
developmentof systemicautoimmunediseases
(SAIDs) in certain individuals, the concordance of SAIDs among identicaltwins is only
25-40%, suggesting that environmentalfactorsplay a substantialrole (Powellet al. 1999).
Indeed,severalenvironmentalagentsareimplicated in triggering or accelerating SAIDs,
includingmercury,iodine, vinyl chloride,certain pharmaceuticals, and crystalline silica.
However, much more researchis needed to
determinethe mechanismsand epidemiology
linking exposuresto development of SAIDs.
There is considerableepidemiologicevidence
supporting the hypothesis that occupational
silica exposureis associatedwith a varietyof
SAIDs, including SSc, rheumatoid arthritis
(RA), systemic lupus erythematosus (SLE),
glomerulonephritis,and small vesselvasculitis
(Koegeret al. 1995; Parkset al. 1999, 2002;
Powell et al. 1999; Steenlandand Goldsmith
1995). Researchregardingasbestosexposure
and SAIDshas been much morelimited.
Asbestos-relatedlung diseasecontinues to
be a serious and significant problem worldwide despite increasing awarenessof health

hazardsof asbestosinhalation.Asbestosexposureis associatedwith variouslung conditions,
includingfibrosis,pleuralplaques,and cancer.
Althoughthe exact mechanismsleadingto the
progressionof these conditionshave not been
fully explained,there is evidencethat some of
the lung abnormalitiesseen with both asbestos
and silica exposures are immunologically
mediated(Hamilton et al. 1996; Holian et al.
1997; Perkinset al. 1993). Nevertheless,it is
unclear how these innate immune responses
might translateto specifichumoralresponses.
Increasedserum immunoglobulins(Ig), positive antinuclear antibody (ANA) tests, and
immune complexes have been reported in
small cohorts of individuals exposed to
asbestos (Lange 1980; Nigam et al. 1993;
Pfau et al. 2005; Zerva et al. 1989), but no
comprehensivestudy has been undertakento
assessthe associationbetween asbestosexposureand autoimmunedisease.
Our majorobjective,therefore,is to establish whethersuch an associationexists,and the
community of Libby, Montana, provides a
unique opportunity to investigate this question. Individuals in this population experienced significantexposuresthat occurredas a
result of asbestos-contaminatedvermiculite
mining near the community. From the early
1920s to 1990, the world'slargestvermiculite
deposits,located near Libby,were mined and

processed. Vermiculite is a silicate mineral
with unique propertiesand numerous commercial applications (Lockey 1984). The
fibrousmineralscontaminatingLibby vermiculite have been characterizedas both regulated asbestosfibers (e.g., tremoliteand other
amphiboleforms)and unregulatedfibers(e.g.,
winchite and richterite)(Meekeret al. 2003).
The variousmining, transportation,and processing activities as well as the personal and
commercialuse of vermiculitein the community have led to widespread environmental
exposuresin the Libbyareawith this asbestoscontaminatedvermiculite. Potential asbestos
exposuresin this communityhave been documentednot only in the minersbut alsoin their
family members as well as anyone who used
the vermiculiteor playednearthe mine tailings
(Dixon et al. 1985). A mortalitystudy in this
communityfound more than 40-fold increases
in standardizedmortalityratiosfor asbestosis,
and elevated mortality also was observedfor
malignant neoplasm of respiratory and
intrathoracic
organs(Hortonet al., in press).
Recently,the Agencyfor Toxic Substances
and Disease Registry(ATSDR) conducted an
extensivescreeningprogramof > 7,300 individuals from this community (Peipins et al.
2003). The initial results of this screening
programidentifiedvariousroutes of exposure
in the community and how those routes of
exposurewere associatedwith abnormalities
on chest radiographs(Peipinset al. 2003). In
addition, when the ATSDR performed its
screening in Libby during 2000-2001, 494
(6.7%) participantsindicated that they had
been diagnosed with SLE, SSc, or RA
(Noonan et al. 2005). By comparison, a
prevalenceof < 1% for these three conditions
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combinedwould be expectedbasedon pooled
estimates from 43 prevalence studies
(acobson et al. 1997). In the present study,
we take these data a step furtherby exploring
the associationof these systemicautoimmune
conditionswith variousparametersof asbestos
and/or vermiculite exposure using a nested
case-controlapproach.

Materials and Methods
All human subjects provided informed consent for this study under a protocol approved
by the institutional review board for the
Centers for Disease Control and Prevention.
The detailsof the ATSDR screeningprogram
are describedelsewhere(Peipins et al. 2003).
Briefly,individualswereeligiblefor the screening program if they had resided, worked,
attendedschool, or participatedin otheractivities in the Libby area for at least 6 months
before 31 December 1990. All screeningparticipantswho were > 18 yearsof age and not
pregnant(n = 6,668) were offeredchest radiographs.Two independentB readersevaluated
the radiographsfor each subject for pleural
and parenchymalabnormalities.If these two
readers disagreed regarding the presence of
pneumoconiosis for a subject, a third reader
was used to adjudicate the difference.
Participantswere classified as "positive"for

pleuralor parenchymalabnormalitiesif at least
two of three B readersobserved this type of
abnormalityon chest radiographs.Participants
also receivedspirometrytestingand were consideredto have abnormalfindings if they had
a forcedvital capacity(FVC) < 80% predicted
and a ratio of 1 sec forced expiratoryvolume
(FEV1)to FVC that is > 70% predicted.Data
on exposureto asbestos-contaminatedvermiculite were basedon occupational,residential,
and recreationalhistoriescollected during inperson interviews.Demographicvariablesand
data on other potential covariateswere also
collectedby in-personinterview.
This study was conducted in two phases.
The initial characterizationof cases (n = 494)
with SAIDs were those participantswho, during the 2000-2001 ATSDR screening program, respondedaffirmativelyto the question
"Haveyou everhad rheumatoidarthritis,scleroderma, or lupus?"Potential controls were
those screening participants who answered
negativelyto this question.Controlswere randomly selected from within strataof sex and
10-year age groups at a 3:1 control-to-case
ratio(n = 1,482) (Figure1).
The initial screening question on SAIDs
was collectedonly to identifyscreeningparticipantswith healthconditionsthatcouldhavean
impacton pulmonaryfunctionor fibrosis.The

Initial
analysis

from
Responses
mailedsurvey
(n = 208;42%)

Secondary
analysis
of
MontanaDepartment
Figure1. Caseandcontrolselectionfrominitialscreeningpopulation.
DPHHS,
PublicHealthandHuman
Services.Lupusrefersto SLE.
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second phase of this study involved a mailed
questionnaire to confirm the original selfreportsof SAIDs and to identifywhich of the
threeconditionsthe potentialcaseswerereporting. The follow-upsurveywas mailedto all 494
potential SAID cases for whom current
addresseswere available.The follow-upsurvey
queriedpotentialcaseson whetheror not they
still consideredthemselvesto have one of the
three indicated SAIDs, which SAID(s) they
had, whether or not their SAIDs were diagnosed by a physician,and whetheror not they
were takingmedicationor other treatmentfor
their condition. For those reportingRA, additionalquestionswereaskedto confirmthe type
of arthritison which they were reporting(i.e.,
or generalarthritis).This folRA, osteoarthritis,
was
approvedby the University
low-up survey
reviewboard.
of Montanainvestigational
Analyseswere conducted using unconditional logistic regressionusing SAS (version9;
SASInstituteInc., Cary,NC). The presenceor
absence of SAIDs or a specific autoimmune
diseasein the postmailinganalysiswas used as
the dependentvariable.The variouspathways
of exposureto vermiculiteand/orasbestoswere
consideredas the main independentvariables
of interest.Test for trendwith increasingnumbers of exposurepathwayswas assessedusing
the Cochran-Armitage test. Potential confounders included indications of restrictive
spirometry and the presence of pleural or
parenchymalabnormalities.These pulmonary
features were the main outcomes of the
ATSDR screeningprogramand could be independentlyassociatedwith both asbestosexposure and biomarkersof autoimmunity (Pfau
et al. 2005). For the final unconditionallogistic regressionmodels, all vermiculite/asbestos
exposurepathwaysand otherpotentialriskfactors were considered.Criteriafor inclusion in
the final model includedstatisticalsignificance
of the explanatoryvariable(p < 0.10), the presence of a confoundingeffecton othervariables,
and the fit of the model.

Results
The distributionof SAID subjectsfor selected
characteristics are presented in Table 1.
Among the 494 subjectsrespondingpositively
to the original SAID screening question,
287 (58%) were women. More than 75% of
SAID subjects lived in Libby for at least
15 years. Follow-up mailed questionnaires
were sent to all 494 subjectswho were classified as havingSAIDs in the initialanalysis.Of
these, 208 (43%) participants responded.
Among those responding, 161 participants
confirmedthat they had a physician-diagnosed
SAID. The proportionaldistributionof those
SAIDswas simireportingphysician-diagnosed
lar to the original 494 who reported SAIDs
with regardto sex, age, smoking history, and
yearslived in Libby (Table 1). Among those
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SAIDs, 129 parreportingphysician-diagnosed
ticipants indicated that they had physiciandiagnosedRA, 70% of whom took medication
for RA. Thirty participantsindicatedthat they
had physician-diagnosedSLE, 63% of whom
took medicationfor SLE.Anotherfour participants indicatedthat they had SSc, and two of
those took medicationfor SSc.
Considering the initial case group
(n = 494), the distribution of years of residence was not differentfor casesand controls
(X2 = 0.57, p < 0.90). Current and former
smokers were more common among SAID
subjects[odds ratio (OR) = 1.72; 95% confidence interval (CI), 1.22-2.44]. SAIDs also
were associatedwith parenchymalabnormalities and with restrictive spirometry but not
stronglywith pleuralabnormalities(Table 2).
These associationsremainedconsistent when
evaluatingthose reportingphysician-diagnosed
SAIDs (n = 161) (Table 2). Both restrictive
spirometryand parenchymalabnormalitiesas
well as current or former smoking were
included in the unconditionallogistic regression models for vermiculite/asbestosexposure
and riskof SAIDs.
The adjusted ORs for various potential
exposurepathwaysto vermiculiteand asbestos
and risk of SAIDs are presented in Table 3.
Previous occupation with the mining company yielded no overall increased risk for
SAIDs (OR = 1.03; 95% CI, 0.69-1.58).
However, we observedelevatedORs for previous occupation with the mining company
among those > 65 yearsof age at the time of
the screening, particularly for RA. Among
other occupational vermiculite exposures,
"dust or vermiculite exposure at jobs other
than W.R. Grace/Zonolite" was the most
consistently associatedwith reportingof any
SAID or RA specifically.Among other occupations with potential exposure to asbestos,
only those reportingasbestosexposurein the
militarywere at increasedrisk for SAIDs and
RA, yielding ORs of 1.70 and 2.11, respectively. Several reported activities or experiences were associated with increased risk of
any SAID or RA specifically.Consideringall
exposure pathways collectively, increasing
opportunitiesfor vermiculiteand/or asbestos
exposureyielded increasingrisk estimatesfor
SAIDs and RA (Table 4). Although the number of SLE cases was too small (n = 30) to
evaluate for trend as in Table 4, we did
observean elevatedriskfor SLE among those
with more than three pathways of exposure
versus those with three or fewer pathwaysof
exposure(OR = 4.45; 95% CI, 1.24-16.00).
We did not observesufficientnumbersof SSc
casesto evaluatethis diseaseby asbestosexposurepathways.
Table 5 presents final unconditional
logistic regressionmodels in which all exposure pathwaysand other potential risk factors

were consideredfor their contribution to the SAIDs and RA. For this age group,workingat
risk of SAIDs and RA. Becauseolder partici- W.R. Grace/Zonolitealso resultedin a 3-fold
pants had differingoccupationalrisk factors, greaterrisk for RA. Elevated ORs were also
we constructedmodels stratifiedby age. For observed for several nonoccupational expoparticipants< 65 yearsof age, dust or vermi- suresto vermiculite(Table5).
culite exposure at jobs other than W.R.
Grace/Zonolite was the only occupational Discussion
exposurethat remainedin the models for both Although there is considerableepidemiologic
SAIDs and RA. For participants> 65 yearsof evidencesupportingthe hypothesisthat occuage, asbestosexposurein the militaryyielded pational silica exposure is associated with a
substantiallyelevated risk estimates for both varietyof SAIDs, researchregardingasbestos
Table1. Distribution
forparticipants
[n(%)]of selectedcharacteristics
anySAID,RA,orSLE.
reporting
Characteristic

Sex
Male
Female
Age(years)c
17-44
45-64
>65
Smoking
history
Never
Ex-smoker
Current
YearslivedinLibby
0.5-14
15-27
28-39
> 40

SAIDsa
(n= 494)

SAIDsb
(n= 161)

RA(n= 129)

SLE(n= 30)

207(41.9)
287(58.1)

69(42.9)
92(57.1)

61(47.3)
68(52.7)

2 (6.7)
28(93.3)

69(14.0)
258(52.2)
167(33.8)

18(11.2)
97(60.3)
46(28.6)

15(11.6)
80(62.0)
34(26.4)

5(16.7)
21(70.0)
4(13.3)

163(33.1)
214(43.4)
116(23.5)

51(31.9)
78(48.8)
31(19.4)

35(27.3)
64(50.0)
29(22.7)

11(36.7)
14(46.7)
5(16.7)

0 (0.0)
37(22.9)
28(21.7)
118(23.9)
133(26.9)
36(27.9)
9(30.0)
41(25.5)
12(40.0)
39(30.2)
47(29.2)
120(24.3)
9 (30.0)
26(20.2)
36(22.4)
123(24.9)
onSAIDs.
to original
"Subjects
bSubjects
confirming
physician-diagnosed
responding
screening
question
positively
SAIDs
infollow-up
2000.
asof1January
mailing.
CAge

Table2. AssociationbetweenSAIDsandpositivefindingsforchestradiograph
andpulmonary
function.
Medical
OR(95%Cl) SAIDsb
evaluation
outcome
SAIDsa
(n= 161) OR(95%Cl)
(n=494)
37
2.23(1.50-3.33)
function
testabnormalityc
90
1.76(1.34-2.32)
Pulmonary
Pleural
46
134
1.25(0.87-1.79)
1.15(0.91-1.45)
abnormalityd
27
9
2.62(1.23-5.58)
2.54(1.51-4.27)
Parenchymal
abnormalityd
onSAIDs.
to original
"Subjects
confirming
physician-diagnosed
bSubjects
responding
screening
question
positively
SAIDs
infollow-up
dAtleasttwoofthreeBreaders
<80%predicted
andanFEVi:FVC
ratio> 70%predicted.
CFVC
mailing.
observed
thistypeofabnormality
onchestradiographs.
Table3. AdjustedORsa(95%CIs)forvermiculite/asbestos
exposureandriskof anySAIDor RAspecifiMontana.
cally,Libby,
Exposure
pathway
Potential
tovermiculite
occupational
exposure
Ever
workforW.R.Grace/Zonolite
Age< 65years
Age> 65years
Contract
worker
forW.R.Grace/Zonolite
LivewithW.R.Grace/Zonolite
workers
Dustorvermiculite
atotherjobs
exposure
Potential
to asbestos
occupational
exposure
Worked
orspraying
asbestos
mixing,
cutting,
Worked
inshipyard/ship
construction
Asbestos
inthemilitary
exposure
inconstruction-related
Worked
jobsd
Worked
as a brake
repair
person
Activities
orexperiences
withpotential
exposure
handled
vermiculite
insulation
Frequently
Usedvermiculite
forgardening
recreated
nearRainey
Road
Creek
Frequently
inthevermiculite
Frequently
played
piles
attheballfield
neartheplant
Frequently
played
vermiculite
Frequently
"popped"

SAIDsb
(n= 494)

SAIDsc
(n= 161)

RA(n= 129)

0.57(0.29-1.11)
1.47(0.82-2.63)
1.29(0.89-1.89)
1.19(0.93-1.53)
1.33(1.08-1.64)

0.74(0.29-1.91)
2.14(0.90-5.10)
1.21(0.67-2.20)
1.29(0.88-1.90)
1.54(1.10-2.15)

0.52(0.16-1.70)
3.23(1.31-7.96)
1.29(0.89-1.89)
1.23(0.80-1.90)
1.65(1.14-2.39)

1.39(0.76-2.54)
1.27(0.68-2.37)
1.05(0.62-1.79)
1.21(0.79-1.84)
0.87(0.49-1.55)

0.47(0.11-2.01)
1.23(0.46-3.25)
1.70(0.84-3.44)
1.17(0.60-2.27)
0.65(0.23-1.86)

0.59(0.14-2.53)
1.80(0.72-4.46)
2.11(1.04-4.30)
1.32(0.66-2.65)
0.61(0.19-2.02)

1.34(0.99-1.82) 1.60(1.02-2.52) 1.89(1.17-3.04)
1.31(1.06-1.62) 1.70(1.19-2.43) 1.70(1.15-2.53)
1.50(1.18-1.91) 1.67(1.15-2.43) 1.78(1.19-2.68)
1.39(1.02-1.91) 1.85(1.18-2.92) 2.06(1.27-3.34)
1.19(0.95-1.49) 1.62(1.14-2.30) 1.74(1.18-2.55)
1.39(0.96-2.02) 2.11(1.27-3.52) 1.68(0.92-3.05)
to
forrestrictive
andsmoking
abnormalities,
bSubjects
responding
positively
aAdjusted
history.
spirometry,
parenchymal
dlncludes
infollow-up
SAIDs
onSAIDs.
mailing.
original
confirming
screening
question
CSubjects
physician-diagnosed
andpipefitter.
welder,
finisher,
electrician,
insulator,
roofer,
carpenter,
drywall
plumber,
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exposure and SAIDs has been much more
limited. The preliminaryfindings presented
here support the hypothesis that asbestos
exposure is associated with the presence of
autoimmunedisease.We found increasedrisk
for SAIDs among those reporting occupational and environmental or recreational
exposures to vermiculite and/or asbestos.
Increased risk estimates were found for
increasing numbers of reported exposure
pathways. The risk estimates by exposure
pathwayremainedelevatedand in some cases
increased after restricting the cases to those
who respondedto a follow-upsurveyand confirmed that they had a physician-diagnosed
SAID or RA specifically. We recognize the
limitation of this approach of combining
exposure pathways of unequal intensity and
duration,but it also providesan analysisthat
parallelsthe previously observed findings of
asbestos exposure and lung abnormalitiesin
this population (Peipins et al. 2003). The
multivariableanalysisidentifiedspecificexposure pathwaysthat were independentlyassociated with risk of SAIDs, including older
subjects who had worked for the mining
company.Among older participants,we also
observed increased risk estimates for SAIDs
and RA among those reporting exposure to
asbestosin the military.The risk for military
asbestos exposure was independent of the
elevated risk for previous work at W.R.
Grace/Zonolite and other Libby exposure
pathways. These findings suggested that

correlationof immune abnormalitiesparticularlyin individualswith pleuralplaques(Zerva
et al. 1989), whereas the Japanese study
showed a greatereffectin individualswith diffuse fibrosisbut not pleuralplaques.In addition, a Polish study reportedincreasedANA
frequencyparticularlyin individualsexhibiting
lung functiondeficits(Lange1980).
Despite some inconsistency between the
studies cited above, all of these immunologic
studies illustrate two important considerations. First,asbestosexposureis clearlyassociated with indices of autoimmune responses.
Second, although the details vary, the autoimmune responses appear to correlate with
asbestos-relateddisease,suggestinga possible
role for the autoimmuneresponsesin the diseaseprocess.The temporalrelationshipamong
asbestosexposure,autoimmuneresponse,and
asbestos-related diseases is uncertain and
beyond the scope of the present study.
Nevertheless, our findings of strong associations between asbestos and/or vermiculite
exposureand risk of SAIDs remainedrobust
after adjusting for objectively characterized
pulmonaryconditionsthat could be associated
with asbestosexposure.
As described previously, the initial case
group was based on those who responded
positively to a screening question about
autoimmune conditions. Asbestos exposure
and SAIDs is a relatively novel avenue of
research,so it is not expectedthat participants
would overreport SAIDs because of a suspected association. For the same reason, we
Table4. Crudeandadjusteda
ORs(95%CIs)riskof anySAIDor RAspecifically,bynumberof vermiculite/ would not expect self-reportedasbestosexposure to be differentially misclassified with
asbestosexposurepathways.
respectto SAID status. As a first step toward
SAIDs
RA(n=129)
No.of
(n=161)
improving disease characterization,we conOR
OR
exposure
Adjusted
Adjusted
ducted a mailing to all participantswho indi(95%Cl)
(95%Cl)
Cases/controls OR
pathways Cases/controls OR
an SAID during the initial
0
1.00(Referent)
1.00(Referent)
1.00(Referent) cated having
1.00(Referent)
2/34
1/34
Of thosewho respondedto
program.
1
screening
0.84
0.89(0.16-4.83)
1.01
1.02
5/101
3/101
(0.10-10.23)
2-3
1.28
26/345
1.36(0.31-6.04)
18/345 1.77
1.79(0.23-13.93) the mailing, almost 23% were unable to con4-5
1.49
2.51(0.33-19.18) firmthat they had RA, SLE,or SSc. In general,
32/364
1.60(0.36-7.04) 27/364 2.52
6+
2.56
96/637
2.58(0.60-11.05) 80/637 4.27
3.98(0.53-29.66) when restrictingthe analysesto those reporting
Trendb
p< 0.001
p< 0.001
any physician-diagnosedSAID or RA specififorrestrictive
andsmoking
trend
test.
abnormalities,
aAdjusted
spirometry,
parenchymal
history.
bCochran-Armitage
cally,the riskestimatesfor severalpathwaysof
asbestos and/or vermiculite exposure were
Table5. FinalmodeladjustedORs(95%Cls)forvermiculite/asbestos
exposureandriskof anySAIDor RA increased. Comparisons of risk estimates
Montana.
Libby,
between the originalgroup of suspectedcases
specifically,
and those who reconfirmeddiagnosis should
SAIDs
RA
be made with caution, however,becauseboth
>
< 65years
<
65
65
65
2 years
years
years
Variable
(n=115)
(n=46)
(n=95)
(n=34)
sets of casesarebasedon self-report.
Given the unique circumstancesof com_a
Ever
workforW.R.Grace/Zonolite
3.03(1.17-7.82)
Dustorvermiculite
atother
1.71
1.60(1.07-2.38)
exposure
(1.10-2.66)
jobs
munity asbestos exposure and the resulting
inthemilitary
Asbestos
2.99(1.04-8.59)
3.31(1.00-10.96) screening program, it is also possible that
exposure
forgardening
Usedvermiculite
1.66(1.09-2.53)
3.43(1.34-8.76) there was a case ascertainmenterrorthat was
inthevermiculite
-1.77
Frequently
played
(1.03-3.04)2.75(0.75-10.06) biased with
piles
respect to exposure. Specifically,
vermiculite
4.33(1.59-11.80)
Frequently
"popped"
with
those
historyof asbestosexposure
greater
Restrictive
3.23(1.91-5.47)
-3.09
(1.74-5.47)2.02(0.87-4.72)
spirometry
abnormalities
3.29(1.31-8.25)
2.90(0.95-8.87) would be more likely to have lung abnormaliParenchymal
ties or frank asbestos-related disease and
Current
orformer
smoker
1.82(0.89-3.69) 1.75(1.09-2.82)
1.195,0.75
%2,pvalueb
0.250,0.62
2.349,0.80
1.211,0.88
would have received more intensive medical
"Variable
didnotenterthefinalmodelforthe givendisease/agestratum.
bHosmer-Lemeshow
test;small care.Bettermedicalcarecould, in turn, result
goodness-of-fit
in a higherlikelihoodof being diagnosedwith
p-valuesuggeststhatthefittedmodelis notanadequatemodel.
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asbestosexposurein generalratherthan Libby
vermiculite exposure in particular could be
relevantto SAID etiology.
These findings were consistent with a
recent immunologic study we undertook
among a small group of volunteersfrom this
same Libby community (Pfau et al. 2005).
The results of that study supported the
hypothesis that increasedfrequency of positive ANA would be found in the Libbygroup
comparedto an age- and sex-matchedunexposed population in Missoula, Montana.
Among the Libbyvolunteers,the titers of the
positiveANAs were positivelycorrelatedwith
the length of the individual's estimated
asbestosexposure.Previousstudieshave measured several immune parametersin populations exposed to asbestos. Investigators in
India demonstratedincreasedIgG, IgA, and
positive ANAs in asbestos-exposedindividuals, comparedto controls,even in the absence
of apparentlung disease(Nigam et al. 1993).
This finding suggested that immune alterations may precede the onset of asbestosrelated disease. A high frequency of positive
ANAs was also found in a Japanesegroup of
asbestosplant workers(Tamuraet al. 1993).
Interestingly,a 3-year follow-up study of the
Japanesegroup showed significantcorrelation
of positiveANAs with progressionof disease,
leadingto additionaldiagnosesof asbestosisin
a previously healthy group (Tamura et al.
1996). A study of Greek residentsexposedto
asbestos-contaminatedwhitewash showed a
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